These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 35008722)
1. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma. Wu Q; Berglund AE; MacAulay RJ; Etame AB Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722 [TBL] [Abstract][Full Text] [Related]
2. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats. Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258 [TBL] [Abstract][Full Text] [Related]
3. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969 [TBL] [Abstract][Full Text] [Related]
5. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Tilghman J; Wu H; Sang Y; Shi X; Guerrero-Cazares H; Quinones-Hinojosa A; Eberhart CG; Laterra J; Ying M Cancer Res; 2014 Jun; 74(11):3168-79. PubMed ID: 24710409 [TBL] [Abstract][Full Text] [Related]
6. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma. Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821 [TBL] [Abstract][Full Text] [Related]
8. BIRC3 is a novel driver of therapeutic resistance in Glioblastoma. Wang D; Berglund A; Kenchappa RS; Forsyth PA; Mulé JJ; Etame AB Sci Rep; 2016 Feb; 6():21710. PubMed ID: 26888114 [TBL] [Abstract][Full Text] [Related]
9. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression. Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169 [TBL] [Abstract][Full Text] [Related]
10. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells. Brodie S; Lee HK; Jiang W; Cazacu S; Xiang C; Poisson LM; Datta I; Kalkanis S; Ginsberg D; Brodie C Oncotarget; 2017 May; 8(19):31785-31801. PubMed ID: 28423669 [TBL] [Abstract][Full Text] [Related]
11. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction. Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation. Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714 [TBL] [Abstract][Full Text] [Related]
14. MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation. Hansen LJ; Sun R; Yang R; Singh SX; Chen LH; Pirozzi CJ; Moure CJ; Hemphill C; Carpenter AB; Healy P; Ruger RC; Chen CJ; Greer PK; Zhao F; Spasojevic I; Grenier C; Huang Z; Murphy SK; McLendon RE; Friedman HS; Friedman AH; Herndon JE; Sampson JH; Keir ST; Bigner DD; Yan H; He Y Cancer Res; 2019 Jul; 79(13):3383-3394. PubMed ID: 31040154 [TBL] [Abstract][Full Text] [Related]
15. SMYD2 induced PGC1α methylation promotes stemness maintenance of glioblastoma stem cells. Li M; Zhang Z; He L; Wang X; Yin J; Wang X; You Y; Qian X; Ge X; Shi Z Neuro Oncol; 2024 Sep; 26(9):1587-1601. PubMed ID: 38721826 [TBL] [Abstract][Full Text] [Related]
16. CSNK1D is associated with stemness and invasiveness in glioblastoma. Liu Y; He W; Guo Y; Qu S; Yao F; Liu J; Chai J; Yang Y; Xu T; Liu Y; Yang D; Jia Q; Li M Pathol Res Pract; 2022 Dec; 240():154187. PubMed ID: 36327821 [TBL] [Abstract][Full Text] [Related]
18. The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma. Wu Q; Berglund AE; Macaulay RJ; Etame AB Cells; 2024 May; 13(11):. PubMed ID: 38891074 [TBL] [Abstract][Full Text] [Related]
19. METTL8 links mt-tRNA m Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809 [TBL] [Abstract][Full Text] [Related]
20. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway. Fukasawa K; Kadota T; Horie T; Tokumura K; Terada R; Kitaguchi Y; Park G; Ochiai S; Iwahashi S; Okayama Y; Hiraiwa M; Yamada T; Iezaki T; Kaneda K; Yamamoto M; Kitao T; Shirahase H; Hazawa M; Wong RW; Todo T; Hirao A; Hinoi E Oncogene; 2021 Apr; 40(15):2803-2815. PubMed ID: 33727660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]